丙种免疫球蛋白Fc段糖基化及其生物学活性和功能

丙种免疫球蛋白是血清中重要的糖蛋白,在IgG Fc的297位天冬酰胺位点存在重要的糖基化,连接的糖链能维持IgG重链构像并调节Fc和FcγR结合能力,异常的糖链改变某些蛋白质的抗原特性,激活补体,介导炎症引起免疫失衡.多种疾病都可能伴有异常糖苷化或因缺少糖苷化酶引起.糖苷的功能结构研究已取得一定进展,进一步研究IgG的Fc段不同糖基化对IgG晶体结构及其生物学功能的影响将有助于设计新型生物制品.本文就近年来丙种免疫球蛋白Fc段糖基化及生物学活性与功能、糖蛋白寡糖链等研究进展作一综述.     

miR-10b对MCF10A细胞表达N-糖链 及O-糖链的影响

蛋白质糖基化是蛋白质翻译后修饰之一,对蛋白质功能有重要的调节作用,而异常糖基化在肿瘤的发生、发展以及癌细胞转移过程中起到关键作用.MiRNAs在癌症的发生发展过程中同样起到非常关键的作用,但其如何影响糖基化进而在肿瘤恶性转化过程中发挥生物学功能的研究甚少.本文将miR-10b在人正常乳腺上皮细胞MCF10A中过表达,利用糖类相关基因芯片系统筛选了发生显著变化的糖基转移酶;随后利用本实验室建立的N-糖链及O-糖链测定方法,分析糖链水平的表达差异;最后对关键糖基转移酶基因Fut8、MGAT3及OGT通过荧光定量PCR、蛋白质免疫印迹和凝集素免疫印迹进行了验证,为研究miR-10b在乳腺癌中的作用提供更多糖组学方面的理论基础.     

免疫球蛋白的糖链与自身免疫疾病

随着糖结构分析技术的不断发展和完善,免疫球蛋白（Ｉｇ）的寡糖链在维系蛋白空间构象和生物功能中的作用,及其糖链异常所引起的病理性改变也进一步明确,这也是当今糖生物学研究的重点之一。本文对Ｉｇ的糖链及糖链异常与自身免疫疾病如类风湿关节炎（ＲＡ）、ＩｇＡ型...     

糖蛋白过敏原N-糖链与过敏的相关性研究

糖蛋白是一种含有寡糖链的蛋白质,糖链与蛋白质之间以共价键相连。N-糖蛋白为常见过敏原之一,主要来源于食物、吸入物、昆虫毒素等,能够引起过敏反应。N-糖蛋白过敏原的N-糖链结构影响过敏原与IgE的结合,影响抗原提呈细胞（APC）对过敏原的识别和提呈。本文在介绍与过敏相关的N-糖蛋白、常见N-糖蛋白过敏原的N-糖链结构及与过敏相关的糖基化酶的基础上,进一步分析过敏原N-糖链影响过敏的机制,为临床预防与治疗过敏性疾病提供新的思路。     

细胞膜表面糖链结构与肿瘤转移的关系

连接在天冬酰胺上的N-糖链,连接在丝氨酸和苏氨酸上的O-糖链,连接在丝氨酸上的糖胺聚糖,连接在脂类物质上的糖脂等糖基化修饰在真核细胞表面普遍存在,并调节了细胞的各种功能,它们不仅参与生命活动中正常的生理生化活动,而且于疾病的发生发展密不可分。肿瘤细胞表面糖基异常化,如糖链在表达水平上的差异以及特殊糖链结构的出现,均与肿瘤细胞的侵袭和转移有密切关系。本综述主要介绍了肿瘤细胞糖基化的改变:一些主要的糖基化结构如β1,6分支和唾液酸的表达的增加会使某些肿瘤细胞的迁移能力增强。同时对引起这种变化的作用机制进行了介绍,提出一些潜在的抗肿瘤研究靶点,为肿瘤糖生物学的深入研究提供参考。     

病毒与宿主细胞的糖基化修饰及相关功能

病毒的复制和对宿主的入侵与自身结构蛋白的糖基化修饰密切相关.对于宿主而言,在病毒感染宿主和宿主抗病毒的过程中,宿主的糖基化过程一方面可抑制病毒的复制和入侵,另一方面可促进病毒对宿主的感染,抑制宿主糖苷酶可抑制病毒的复制.从病毒方面来看,由于病毒自身缺乏糖基化修饰系统,病毒的糖基化过程是借宿主细胞内的合成系统对自身进行糖基化修饰.病毒的糖基化过程对病毒蛋白的折叠与稳定、病毒的感染和入侵、参与识别宿主细胞受体和参与病毒的免疫逃逸等过程起着重要的作用.随着糖基化研究技术的发展,以糖基化为基础的功能应用也越来越深入:如新型病毒疫苗和新型抗病毒药物的研制,以糖蛋白质组学研究为基础的质谱技术和生物信息学方法的发展,以及利用糖基化对病毒性疾病的诊断和治疗等,这些均为糖基化深入研究发展奠定了基础.本文就病毒与宿主细胞糖基化过程、相关功能以及研究应用等进展作一综述.     

综述: 病毒与宿主细胞的糖基化修饰及相关功能

病毒的复制和对宿主的入侵与自身结构蛋白的糖基化修饰密切相关．对于宿主而言,在病毒感染宿主和宿主抗病毒的过程中,宿主的糖基化过程一方面可抑制病毒的复制和入侵,另一方面可促进病毒对宿主的感染,抑制宿主糖苷酶可抑制病毒的复制．从病毒方面来看,由于病毒自身缺乏糖基化修饰系统,病毒的糖基化过程是借宿主细胞内的合成系统对自身进行糖基化修饰．病毒的糖基化过程对病毒蛋白的折叠与稳定、病毒的感染和入侵、参与识别宿主细胞受体和参与病毒的免疫逃逸等过程起着重要的作用．随着糖基化研究技术的发展,以糖基化为基础的功能应用也越来越深入：如新型病毒疫苗和新型抗病毒药物的研制,以糖蛋白质组学研究为基础的质谱技术和生物信息学方法的发展,以及利用糖基化对病毒性疾病的诊断和治疗等,这些均为糖基化深入研究发展奠定了基础．本文就病毒与宿主细胞糖基化过程、相关功能以及研究应用等进展作一综述．     

植物N-糖链检测技术研究进展

N-糖基化作为一种重要的蛋白质翻译后修饰,在胚胎发育、癌症发生发展及免疫防御等诸多复杂的生命活动中发挥着关键作用。近年来,基于质谱的N-糖链的检测及其定量研究在动物方面取得了显著进展,相比之下,植物N-糖基化及N-糖链检测的相关研究要远远滞后,这也是制约植物糖生物学研究发展的关键瓶颈问题之一。对蛋白质N-糖链的释放、定量策略、可视化检测及其在植物中的应用进展进行了归纳总结,以期为指导后续植物N-糖链及N-糖组的定性定量检测提供参考。     

N-糖蛋白去糖基化酶（PNGase）的研究进展

N-糖蛋白去糖基化酶（PNGase）是一种广泛存在于真菌、植物、哺乳动物中的去糖基化酶，可以水解N-糖蛋白或 N-糖肽上天冬酰胺与寡糖链连接的化学键，并释放出完整的N-寡糖。PNGase在生物体内参与蛋白质降解、器官发育、个体生长等过程。人PNGase基因功能缺陷会导致先天性去糖基化障碍，小鼠PNGase缺陷会导致胚胎致死性，线虫PNGase缺陷使其寿命下降。本文对PNGase在不同物种的分布、蛋白质结构、酶学功能及生物学功能进行阐述，为PNGase的生理病理功能及致病机制的基础研究提供思路，为PNGase作为糖生物学工具酶或药物开发的创新应用研究奠定基础。     

新型冠状病毒的糖基化、糖受体识别及糖链抑制剂的发现北大核心CSCD

新型冠状病毒疫情(COVID-19)是21世纪截至目前人类面对的最为严重的公共卫生事件。疫苗、中和抗体以及小分子化合药物的出现有效预防和阻止了COVID-19的快速传播,而不断出现的病毒突变体却使这些疫苗及药物的效价降低,这对COVID-19的预防及治疗提出了新的挑战。新型冠状病毒(SARS-CoV-2)通常会先黏附于呼吸道表面的大分子糖链——硫酸乙酰肝素,进而与特异性受体人血管紧张素转化酶2(human angiotensin-converting enzyme 2,hACE2)结合,从而实现对人体的侵入。SARS-CoV-2的刺突(spike,S)蛋白是高度糖基化的,而糖基化对于hACE2与S蛋白的结合也有着重要影响,S蛋白在宿主体内还会被一系列凝集素受体所结合,这意味着糖链在SARS-CoV-2的入侵及感染过程中有着重要的作用。基于SARS-CoV-2的糖基化及糖受体识别机制开发糖链抑制剂可能是预防或治疗新型冠状病毒感染的有效手段,相关研究发现海洋来源的硫酸化多糖、肝素分子及其他的一些糖类具有抗SARS-CoV-2的活性。本文系统阐述了新型冠状病毒的糖基化及其糖链在入侵、感染中的作用,并对抗SARS-CoV-2糖链抑制剂的发现和机制研究现状进行了总结,在此基础上还对糖类抗病毒药物的机遇与挑战进行了展望。     

综述: 串联质谱寡糖结构解析方法评介

糖组学的研究与发展对生命科学及生物医药的发展具有重要的推动作用．寡糖结构的解析是糖组学中重要的研究课题之一．串联质谱分析技术以其具有高特异性及高灵敏度的特点成为了广为使用的寡糖结构解析方法．本文首先概述了串联质谱寡糖结构解析的研究背景;然后介绍了现有的寡糖结构解析策略及基于每种策略的经典解析方法,并对所列方法的原理和算法进行逐一分析讨论;最后,总结现有方法的优缺点,对串联质谱寡糖结构研究领域进行了研究展望．     

寡糖的构象分析

糖在生物体内具有极为重要的生物学功能,其在细胞及分子识别等许多过程中的作用已日益得到重视,糖的结构特征已成为研究识别过程的重要依据.集中介绍了有关寡糖结构的基本概念、理论研究热点及现状,并对有关研究方法进行了评述．寡糖结构理论研究的发展方向之一是研究糖与蛋白质的相互作用以及糖蛋白中糖链的结构与功能.     

寡糖氧化酶研究进展

寡糖氧化酶（oligosaccharide oxidase）是一种新型氧化酶,属于辅助活性家族7（auxiliary activity family 7,AA7）。其可作用的底物范围较广,能够催化多种寡糖氧化成相应的醛酸,并在反应过程中产生过氧化氢。根据寡糖氧化酶的作用底物,可将已报道的寡糖氧化酶分为葡糖寡糖氧化酶（gluco-oligosaccharide oxidase,GOOX）、木寡糖氧化酶（xylo-oligosaccharide oxidase,XOOX）和壳寡糖氧化酶（chito-oligosaccharide oxidase,COOX）等。寡糖氧化酶用途广泛,可应用于食品、医药、饲料、生物燃料等多种领域。但目前国内外对寡糖氧化酶的研究较少。基于此,从基本酶学性质、分子结构、作用机理、酶分子改良及应用等方面对寡糖氧化酶进行了综述,以期为寡糖氧化酶的实际研究及应用提供参考。     

Efficient preparation of glycoprotein hormones lacking an alpha-subunit oligosaccharide

The oligosaccharide on alpha-subunit loop 2 (alpha 2) is needed for full glycoprotein hormone efficacy. Efforts to prepare glycoprotein hormone antagonists usually involve removing the alpha 2 oligosaccharide and are hampered by its requirement for efficient heterodimer secretion from mammalian cells. Here we show that hormones lacking this oligosaccharide can be produced by treating them at low pH to dissociate the heterodimer and permitting the subunits to re-associate in the presence of peptide N-glycosidase F (PNGase F). Re-assembly of human choriogonadotropin, human follitropin, and bovine lutropin occurred rapidly and efficiently following removal of the alpha 2 oligosaccharide by PNGase F. Consequently, virtually all heterodimers formed in the presence of this enzyme lacked this oligosaccharide. These findings support the notion that heterodimer assembly in vitro occurs by a threading mechanism that is impeded by the presence of the alpha 2 oligosaccharide. This procedure should facilitate the study of glycoprotein hormone structure and function.     

Structural analysis of the lipopolysaccharide from Pasteurella multocida genome strain Pm70 and identification of the putative lipopolysaccharide glycosyltransferases

Pasteurella multocida is an important multispecies veterinary pathogen. The cell surface lipopolysaccharide (LPS) is an important virulence factor and forms the basis of the serotyping scheme, although little structural information about it is known. The structure of the LPS from the Pasteurella multocida genome strain Pm70 was elucidated in this study. The LPS was subjected to a variety of degradative procedures. The structures of the purified products were established by monosaccharide and methylation analyses, NMR spectroscopy, and mass spectrometry. The structure of the core oligosaccharide was determined on the basis of the combined data from these experiments. Identification of the core oligosaccharide structure enabled a search for glycosyltransferase homologs in the Pm70 genome and revealed a clustering of the genes putatively responsible for outer core oligosaccharide biosynthesis.     

Structural analysis of the core oligosaccharide from Pasteurella multocida strain X73

The structure of the core oligosaccharide region of the lipopolysaccharide from the Pasteurella multocida strain X73 was elucidated. The lipopolysaccharide was subjected to a variety of degradative procedures. The structure of the purified oligosaccharide was established by monosaccharide and methylation analyses, NMR spectroscopy and mass spectrometry. The following structure illustrates a similar structure to the recently identified oligosaccharide from another P. multocida strain VP161, but with additional symmetrical substitution of the terminal galactose residues with phosphoethanolamine moieties, where based on the NMR data all sugars were found in pyranose ring forms and Kdo is 3-deoxy-alpha-D-manno-2-oct-2-ulosonic acid, l,D-alpha-Hep is l-glycero-D-manno-heptose, PEtn is phosphoethanolamine and PCho is phosphocholine.     

大豆低聚糖对肠道菌群结构调节的研究

目的 :对山松牌大豆低聚糖对肠道菌群调节的效果进行研究。方法 :通过动物实验和人体试验。结果 :山松牌大豆低聚糖能增殖体内乳杆菌和双歧杆菌数量 ;在较高剂量时 ,能使体内的肠球菌和肠杆菌增殖。采用B/E值 (即双歧杆菌和肠杆菌的比值 )作为指标进行分析发现 ,该制品在低剂量时能更好地优化肠道菌群结构。结论 :大豆低聚糖对肠道菌有较好的调节效果     

Role of glycosylation in structure and stability of Erythrina corallodendron lectin (EcorL): a molecular dynamics study

The effect of glycosylation on structure and stability of glycoproteins has been a topic of considerable interest. In this work, we have investigated the solution conformation of the oligosaccharide and its effect on the structure and stability of the glycoprotein by carrying out a series of long Molecular dynamics (MD) simulations on glycosylated Erythrina corallodendron lectin (EcorL) and nonglycosylated recombinant Erythrina corallodendron lectin (rEcorL). Our results indicate that, despite the similarity in overall three dimensional structures, glycosylated EcorL has lesser nonpolar solvent accessible surface area compared to nonglycosylated EcorL. This might explain the experimental observation of higher thermodynamic stability for glycosylated EcorL compared to nonglycosylated EcorL. Analysis of the simulation results indicates that, dynamic view of interactions between protein residues and oligosaccharide is entirely different from the static picture seen in the crystal structure. The oligosaccharide moiety had dynamically stable interactions with Lys 55 and Tyr 53, both of which are separated in sequence from the site of glycosylation, Asn 17. It is possible that glycosylation helps in forming long-range contacts between amino acids, which are separated in sequence and thus provides a folding nucleus. Thus our simulations not only reveal the conformations sampled by the oligosaccharide, but also provide novel insights into possible molecular mechanisms by which glycosylation can help in folding of the glycoprotein by formation of folding nucleus involving specific contacts with the oligosaccharide moiety.     

Quantitation and structures of oligosaccharide chains in human trachea mucin glycoproteins

Human respiratory mucin glycoproteins from patients with cystic fibrosis were purified and oligosaccharide chains were released by treatment with alkaline borohydride. A neutral oligosaccharide alditol fraction was isolated from mucin obtained from a patient with A blood group determinant by chromatography on DEAF-cellulose and individual oligosaccharide chains were then isolated by gel filtration on BioGel P-6 columns and high performance liquid chromatography with gradient and isocratic solvent systems. The structures of the purified oligosaccharides were determined by methylation analysis, sequential glycosidase digestion and H-NMR spectroscopy. The amount of each chain was determined by compositional analysis. A wide array of discrete branched oligosaccharide structures that contain from 3 to 22 sugar residues were found. Many of the oligosaccharides are related and appear to be precursors of larger chains. The predominant branched oligosaccharides which accumulate contain terminal blood group H (Fuc2Ga14) or blood group A (Fuc2(Ga1NAc3) (Ga14) determinants which stop further branching and chain elongation. The elongation of oligosaccharide chains in respiratory mucins occurs on the 3-linked G1cNAc at branch points, whereas the 6-linked GlcNAc residue ultimately forms short side chains with a Fuc2 (Ga1NAc3) Gal4 G1cNAc6 structure in individuals with A blood group determinant.The results obtained in the current studies further suggest that even higher molecular weight oligosaccharide chains with analogous branched structures are present in some human respiratory mucin glycoproteins. Increasing numbers of the repeating sequence shown in the oligosaccharide below is present in the higher molecular weight chains. {ie75-1} This data in conjunction with our earlier observations on the extensive branching of these oligosaccharide chains helps to define and explain the enormous range of oligosaccharide structures found in human and swine respiratory mucin glycoproteins. Comparison of the relative concentrations of each oligosaccharide chain suggest that these oligosaccharides represent variations of a common branched core structure which may be terminated by the addition of a2-linked fucose to the 3/4 linked galactose residue at each branch point. These chains accumulate and are found in the highest concentrations in these respiratory mucins.     

人胎盘纤连蛋白N糖链结构研究

分离纯化了人胎盘纤连蛋白（Ｆｎ）,经ＳＤＳ－ＰＡＧＥ鉴定为一条带,纯化Ｆｎ仍保持其搞原性,得率为３８．７％。根据植物凝集素识别专一糖链结构的原理,应用斑点印迹法,亲和层析法和Ｗｅｓｔｅｒｎ转移电泳研究糖链结构,结果证实：１．人胎盘Ｆｎ分子中含有复杂型Ｎ糖链（包括二天线和大于二天线的结构）以及高甘露糖型和／或杂合型Ｎ糖链;复杂型Ｎ糖链中含有平分型ＧｌｃＮＡｃ,糖链末端也可连有唾液酸;２．胰糜蛋白酶水解而获得的明胶结合片段（４４ｋＤ）含有二天线和多天线复杂型糖链,也可接有平分型ＧｌｃＮＡｃ;３．肝素结合片段（３０ｋＤ）以及明胶、肝素均不结合的Ｆｎ片段不含有多天线复杂型Ｎ糖链。